Loading...
XSWX
ALC
Market cap31bUSD
Sep 17, Last price  
53.44CHF
1D
-3.01%
1Q
1.10%
IPO
-7.29%
Name

Alcon AG

Chart & performance

D1W1MN
XSWX:ALC chart
P/E
32.24
P/S
3.04
EPS
2.01
Div yield, %
0.52%
Shrs. gr., 5y
0.29%
Rev. gr., 5y
8.77%
Revenues
10.40b
+4.94%
6,517,955,3426,596,000,0006,792,000,0007,153,000,0007,508,000,0006,833,000,0008,291,000,0008,717,000,0009,455,000,0009,911,000,00010,401,000,000
Net income
980m
-3.73%
296,270,697-170,000,000256,000,000-227,000,000-656,000,000-531,000,000376,000,000335,000,000974,000,0001,018,000,000980,000,000
CFO
2.27b
+9.34%
1,317,827,4521,245,000,0001,218,000,0001,140,000,000920,000,000823,000,0001,345,000,0001,217,000,0001,388,000,0002,077,000,0002,271,000,000
Dividend
May 05, 20260.28 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.

Related entities

Subsidiaries (7)
ALCON LABORATORIES (INDIA) PRIVATE LIMITED
Alcon Laboratories Belgium
ALCON MANAGEMENT SA
ALCON PHARMACEUTICALS LTD
ALCON SINGAPORE MANUFACTURING PTE. LTD.
ALCON FINANCE B.V.
ALCON FINANCE CORPORATION

Key people

Chief Financial Officer · since 2019
Ian Bell
President - International · since 2018
Sergio Duplan
President - North America · since 2015
Michael Onuscheck
President - Global Businesses and Innovation · since 2018
David J. Endicott
Chief Executive Officer, Director · since 2018
Dieter Spalti
Independent Director
IPO date
Apr 09, 2019
Employees
25,000
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
RUE LOUIS-D'AFFRY 6
FRIBOURG, FR 1701
CH

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT